Mergers & Acquisitions - Mergers & Acquisitions, Generics

Filter

Popular Filters

101 to 125 of 190 results

American Capital commits $212 million to acquire Cambridge Major Laboratories

03-01-2013

Private equity firm American Capital (Nasdaq: ACAS) says that it has committed $212 million in the buyout…

American CapitalBiotechnologyCambridge Major LaboratoriesGenericsMergers & AcquisitionsPharmaceutical

JHP Pharmaceuticals acquired by Warburg Pincus for $195 million

02-01-2013

US specialty drugmaker JHP Pharmaceuticals, which acquires, develops, manufactures and sells sterile…

GenericsJHP PharmaceuticalsMergers & AcquisitionsPharmaceuticalWarburg Pincus

Perrigo buys full control of Cobrek Pharma for about $45 million

31-12-2012

US drugmaker Perrigo (Nasdaq: PRGO; TASE) announced on Friday that it has signed a definitive merger…

Cobrek PharmaceuticalsGenericsMergers & AcquisitionsPerrigoPharmaceutical

DCC Healthcare acquires generic drugmaker Kent Pharma

24-12-2012

Dublin, Ireland-based sales, marketing, distribution and business support services group DCC, says that…

Antibiotics and Infectious diseasesDCC HealthcareGenericsKent PharmaceuticalMergers & Acquisitions

No "Japan pharma for sale signs," by P Reed Maurer

18-12-2012

Want to acquire a Japanese pharmaceutical company? Join the back of a long line of companies with the…

Asia-PacificGenericsMergers & AcquisitionsPharmaceutical

News briefs: US Crestor patent upheld; Pfizer animal health plans; Teva South Korea JV

17-12-2012

Anglo-Swedish drug major AstraZeneca (LSE: AZ) said on Friday that the US Court of Appeals for the Federal…

Asia-PacificAstraZenecaCrestorGenericsHandok PharmaceuticalsLegalMergers & AcquisitionsNorth AmericaPatentsPfizerPharmaceuticalTeva Pharmaceutical IndustriesZoetis

Kemira sells ChemSolutions' food and pharma businesses to Niacet

16-12-2012

Finland-based water chemistry specialist Kemira Oyj (OMX: KRA1V) has signed an agreement to sell its…

GenericsKemiraMergers & AcquisitionsNiacet

India's Elder Pharma to enter EU markets; comment on GSK Indian OTC moves

26-11-2012

Indian drugmaker Elder Pharmaceuticals says it is ready to enter the European Union market following…

Asia-PacificdiosminElder PharmaceuticalsEuropeGenericsGlaxoSmithKlineMarkets & MarketingMergers & AcquisitionsPharmaceuticalRegulation

Impax in deal with Perrigo; Cipla eyes South Africa acquisition

22-11-2012

Impax Laboratories (Nasdaq: IPXL) said yesterday that it plans to collaborate with fellow US drugmaker…

CiplaCipla MedproGenericsImpax LaboratoriesMarkets & MarketingMergers & AcquisitionsNorth AmericaPerrigoResearchRest of the World

Validus Pharma gets rights to six Novartis drugs in USA

19-11-2012

USA-based Validus Pharmaceuticals (NYSE: VR) together with Wood Creek Capital Management, have acquired…

GenericsMergers & AcquisitionsNovartisValidus Pharma

Pernix splashes out over $100 million to buy Cypress Pharma and Hawthorn Pharma

15-11-2012

US specialty drugmaker Pernix Therapeutics (NYSE: PTX) has entered into a definitive agreement to acquire…

Cypress PharmaceuticalsFinancialGenericsHawthorn PharmaceuticalsMergers & AcquisitionsPernix TherapeuticsPharmaceutical

AFK Sistema cleared to take over Russian drugmaker Veropharm

14-11-2012

Shares in Russian companies 36.6 and Veropharm surged in Monday afternoon trading on the Moscow Stock…

AFK SistemaGenericsMergers & AcquisitionsPharmaceuticalRegulationVeropharm

AFK Sistema may acquire Russian drugmaker Veropharm

06-11-2012

AFK Sistema, the financial conglomerate owned by the Russian billionaire Vladimir Yevtushenko, is considering…

AFK SistemaGenericsMergers & AcquisitionsPharmaceuticalVeropharm

Forest Labs links with moksha8 for Viibryd in Latin America; Watson sells minority stake

24-10-2012

US drugmaker Forest Laboratories (NYSE: FRX) has entered into a broad strategic alliance with Brazil-based…

Forest LaboratoriesGenericsLicensingMergers & AcquisitionsMoksha8NeurologicalPharmaceuticalSouth AmericaViibrydWatson Pharmaceuticals

Pfizer to buy NextWave Pharma for as much as $680 million

23-10-2012

Global drugs behemoth Pfizer (NYSE: PFE) revealed yesterday that it is prepared to pay up to $680 million…

GenericsMergers & AcquisitionsNextWave PharmaceuticalsPfizerPharmaceuticalQuillivant

India's Dr Reddy's to acquire OctoPlus for $35.7 million

22-10-2012

India's second largest drugmaker Dr Reddy's Laboratories (NYSE: RDY) announced this morning that it intendeds…

Dr Reddy's LaboratoriesGenericsMergers & AcquisitionsOctoPlusPharmaceutical

Alvogen to acquire majority stake in Kunwha Pharma; Alliance buys Opus

21-10-2012

Privately-held US drugmaker Alvogen last Friday entered into an agreement to acquire a majority share…

Alliance PharmaAlvogenGenericsKunwha PharmaMergers & AcquisitionsOpus GroupPharmaceutical

Mylan buys Indian production unit from SMS Pharma for $33 million

18-10-2012

Following speculation that started last month, India's SMS Pharmaceuticals this week confirmed that it…

Asia-PacificGenericsMergers & AcquisitionsMylan LaboratoriesProductionSMS Pharmaceuticals

US FTC puts divestment conditions on Watson's acquisition of Actavis

16-10-2012

The USA's Federal Trade Commission will require Watson Pharmaceuticals (NYSE: WPI) and fellow generic…

ActavisGenericsLegalMergers & AcquisitionsNorth AmericaNovartisPar PharmaceuticalsSandozWatson Pharmaceuticals

Cinven snaps up Amdipharm for £367 million

15-10-2012

Channel Islands-based private equity firm Cinven has reached agreement to acquire UK-based niche generic…

AmdipharmCinvenGenericsMercury PharmaMergers & Acquisitions

BioSante and ANI Pharma agree all-stock merger

05-10-2012

USA-based BioSante Pharmaceuticals (Nasdaq: BPAX) and privately-held specialty and generic drugmaker…

ANI PharmaceuticalsBioSante PharmaceuticalsGenericsMergers & AcquisitionsPharmaceutical

TPG completes $1.9 billion acquisition of Par Pharma

01-10-2012

Par Pharmaceuticals (NYSE: PRX), a USA-based maker of generic drugs and niche innovative proprietary…

GenericsMergers & AcquisitionsPar PharmaceuticalsTPG

101 to 125 of 190 results

Company Spotlight

ImmunoGen

ImmunoGen

Back to top